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Abstract
Background—Considerable uncertainty remains about obstructive lung function (OLF) in adults 
with metabolic syndrome (MetS). The aim of the present study was to examine pulmonary 
function status in adults with and without MetS.
Methods—We used data from 3109 participants aged ≥20 years of the National Health and 
Nutrition Examination Survey 2007–2010. Subjects’ MetS status was established on the basis of 
the 2009 harmonizing definition. Participants received spirometry.
Results—After age adjustment, 79.3% (SE 1.1) of participants with MetS had normal lung 
function, 8.7% (0.9) had restrictive lung function (RLF), 7.1% (0.8) had mild OLF, and 4.8% (0.6) 
had moderate OLF or worse. Among participants without MetS, these estimates were 78.7% (1.2), 
3.9% (0.6), 10.9% (1.1), and 6.4% (0.8), respectively. After multiple adjustment, participants with 
MetS were more likely to have RLF (adjusted prevalence ratio [aPR] 2.20; 95% confidence 
interval [CI] 1.67, 2.90) and less likely to have any OLF (aPR 0.73; 95% CI 0.62, 0.86) than those 
without MetS. Furthermore, participants with MetS had lower mean levels of forced expiratory 
volume in one second (FEV1), FEV1 % predicted, forced vital capacity (FVC), and FVC % 
predicted, but a higher FEV1/FVC ratio than participants without MetS. Mean levels of FEV1, 
FEV1 % predicted, FVC, and FVC % predicted declined significantly, but not the FEV1/FVC 
ratio, as the number of components increased.
Conclusions—Compared with adults without MetS, spirometry is more likely to show a 
restrictive pattern and less likely to show an obstructive pattern among adults with MetS.
*The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the 
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Introduction
The metabolic syndrome comprises a constellation of cardiometabolic abnormalities, 
including abdominal obesity, hypertriglyceridemia, low high-density lipoprotein–cholesterol 
(HDL-C), elevated blood pressure, and hyperglycemia. The syndrome is highly prevalent in 
many countries, including the US, where approximately 35% of adults have the metabolic 
syndrome based on the 2009 harmonizing definition.1 In general, adults with metabolic 
syndrome show clinical or subclinical evidence of dysfunction of multiple organs. However, 
with regard to the pulmonary system, questions remain about potential differences in 
pulmonary function in adults with and without metabolic syndrome. Most of the large-scale 
studies investigating the associations between pulmonary function and metabolic syndrome 
have been conducted in Asian populations and, in the aggregate, indicate that metabolic 
syndrome is characterized by restrictive rather than obstructive lung function.2–8 The 
associations between metabolic syndrome components and respiratory patterns have 
received less attention. Because information about the association between the metabolic 
syndrome and pulmonary function from population-based studies in the US is relatively 
scarce and an improved understanding of lung function in people with metabolic syndrome 
may have implications for their clinical management, we examined this issue in a national 
sample of adults.
Methods
The present study included data from the National Health and Nutrition Examination Survey 
(NHANES) 2007–2010. A stratified multistage probability sampling design was used to 
select participants. Those who agreed to participate were interviewed in their homes and 
asked to have an examination in the mobile examination center. During the examination, 
attendees completed additional questionnaires, underwent a series of examinations, and had 
phlebotomy. Response rates for the interview and examination were 78% and 75%, 
respectively, in NHANES 2007–2008 and 79% and 77%, respectively, in NHANES 2009–
2010. Details about the surveys may be found elsewhere.9 Because we used data freely 
available in the public domain, our study was exempt from human subjects review.
Metabolic syndrome was defined according to criteria published in the 2009 Joint Scientific 
Statement.10 Waist circumference was measured at the high point of the iliac crest at 
minimal respiration to the nearest 0.1 cm. Abdominal obesity was defined using the 
following thresholds: waist circumference ≥102 cm in men and ≥88 cm in women for 
participants who were white, African American or of another race, and a waist 
circumference ≥90 cm in men and ≥80 cm in women for participants who were Mexican 
American or another Hispanic ethnicity. Serum triglyceride concentrations were measured 
enzymatically after hydrolyzation to glycerol (Roche Modular P chemistry analyzer, Roche, 
Indianapolis, IN, USA), and HDL-C was measured after non-HDL-C fractions were 
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complexed with a magnesium–dextran sulfate solution (Roche Modular P chemistry 
analyzer). Plasma glucose concentrations were measured using the hexokinase assay (Roche 
Modular P chemistry analyzer). For participants who had three blood pressure 
measurements, the average of the last two measurements of blood pressure was used. For 
participants with two measurements, the last measurement was used, and for participants 
who had one measurement, that single measurement was used to establish high blood 
pressure status. Diabetes was defined as diagnosed diabetes or, among adults without 
diagnosed diabetes,a fasting plasma glucose concentration ≥126 mg/dL.
Spirometry was offered to participants aged 6–79 years in NHANES 2007–2010, and we 
used data only for adults aged 20–79 years. Exclusion criteria included: current chest pain; 
physical problems with forceful expiration; the use of supplemental oxygen; recent surgery 
of the eye, chest or the abdomen; recent heart attack, stroke, tuberculosis exposure or 
coughing up of blood; and history of detached retina, collapsed lung, or aneurysm. 
Spirometry was performed with Ohio 822/827 dry-rolling seal volume spirometers (Ohio 
Medical Instrument Company), and participants were asked to provide three acceptable 
maneuvers.
Predictive equations for calculating forced expiratory volume in 1 s (FEV1) and forced vital 
capacity (FVC) were based on those developed from NHANES III data.11 Using the Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) classification of chronic 
obstructive pulmonary disease (COPD) severity, which is based on post-bronchodilator 
spirometric results, we defined severe obstructive impairment as FEV1/FVC <0.70 and 
FEV1 <50% predicted, moderate obstructive impairment as FEV1/FVC <0.70 and FEV1 
between 50% and <80% predicted, and mild obstructive impairment as FEV1/FVC <0.70 
and FEV1 ≥80% predicted.12 Participants with an FEV1/FVC ratio ≥0.70 were divided into 
those with normal pulmonary function if their FVC was ≥80% predicted and those with 
restrictive function if their FVC was <80% predicted.
Covariates included age, gender, race or ethnicity (white, African American, Mexican 
American, and other), educational status (<12 years, high school graduate or equivalent, 
education beyond high school), smoking status (current, former, never), recreational 
physical activity, alcohol use, C-reactive protein (CRP) concentration, and body mass index 
(BMI). A current smoker was defined as someone who had smoked at least 100 cigarettes 
during his or her lifetime and reported currently smoking. A former smoker was defined as 
someone who had smoked at least 100 cigarettes during his or her lifetime but reported 
having stopped smoking. A never smoker was defined as someone who had not smoked at 
least 100 cigarettes during his or her lifetime. Metabolic equivalent (MET)-hours of 
recreational physical activity were calculated by summing the products of reported weekly 
hours of moderate and vigorous physical activity multiplied by their respective MET levels. 
The daily intake of alcohol drinks was established from a series of questions about the 
frequency of consumption of alcoholic beverages and average number of drinks on days that 
alcoholic beverages were consumed. Concentrations of CRP were measured using high-
sensitivity nephelometry (N Latex CardioPhase hsCRP Reagent [Siemens Healthcare 
Diagnostics, Deerfield, IL, USA] and Dade Behring Nephelometer II Analyzer System 
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(BNII) [Dade Behring Diagnostics, Somerville, NJ, USA]). Body mass index was calculated 
from measured weight and height.
Analyses were limited to men and non-pregnant women aged ≥20 years. The direct method 
was used to calculate age-adjusted estimates of the prevalence of pulmonary function 
categories by using the projected Year 2000 US population. Analysis of covariance was 
used to calculate age-adjusted and multiple-adjusted mean levels of FEV1, FVC, % 
predicted FEV1, % predicted FVC, and FEV1/FVC ratio. The significance of differences 
between mean values was tested with t-tests. The significance of differences for 
dichotomous variables was tested with Chi-squared tests or Wald Chi-squared tests in log-
linear models. Tests for trend for pulmonary function parameters by number of 
cardiometabolic components were conducted with linear regression analyses. Data were 
managed using SAS (SAS Institute, Cary, NC, USA), and final estimates using sampling 
weights were produced with SUDAAN (RTI International, Research Triangle Park, NC, 
USA) to account for the complex sampling design.
Results
Of the 4932 men and non-pregnant women aged ≥20 years who attended the morning 
examination, data to establish metabolic syndrome and pulmonary function status were 
available for 4626 and 3846 participants, respectively (3721 had complete information for 
both). Subsequent deletions for missing covariate values reduced the analytic sample size to 
3553. Limiting the sample to participants who had acceptable spirometric efforts resulted in 
a final analytic sample size of 3109 participants.
Among all 3109 participants, the unadjusted prevalence of metabolic syndrome was 34.3% 
(SE 1.2). Furthermore, 79.3% (1.1) had normal lung function, 6.0% (0.6) had a restrictive 
pattern, 9.0% (0.8) had mild obstructive impairment, 5.1% (0.6) had moderate obstructive 
impairment, and 0.6% (0.2) had severe or very severe obstructive impairment.
Compared with participants who did not have metabolic syndrome, those with metabolic 
syndrome were older, more likely to be male, and more likely to have less education (Table 
1). Significant differences in mean age and the percentage of men, whites, and adults with 
>12 years of education were present among categories of pulmonary function status.
Adults with metabolic syndrome showed evidence of having more restrictive lung 
impairment and less mild obstructive impairment than those without metabolic syndrome 
(Table 2). Among the metabolic syndrome components, this pattern was replicated for 
abdominal obesity, hypertriglyceridemia, and low HDL-C. A higher percentage of 
participants with hyperglycemia also showed evidence of restrictive lung impairment than 
those with normoglycemia. In multivariate regression models, metabolic syndrome and all 
five components were significantly associated with the presence of restrictive impairment 
(Table 3). In contrast, metabolic syndrome, abdominal obesity, and hypertriglyceridemia 
were inversely associated with any obstructive impairment.
After adjusting for a series of covariates, participants with metabolic syndrome had lower 
mean levels of FEV1, FEV1 % predicted, FVC, and FVC % predicted but a higher 
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FEV1/FVC ratio than participants without metabolic syndrome (Table 4). Most of these 
differences persisted after adjusting for BMI as well. For the individual components, the 
pattern of significant differences proved somewhat variable. Low HDL-C and elevated 
blood pressure had the most consistent pattern of significant differences. After adjusting for 
metabolic syndrome components, several of the differences were attenuated to the point of 
losing statistical significance. Mean levels of FEV1, FEV1 % predicted, FVC, and FVC % 
predicted decreased significantly as the number of components increased (Table 5). Results 
stratified by BMI categories corresponding to Tables 4 and 5 are presented in Tables S1 and 
S2, respectively, available as Supporting Information for this paper.
We also examined pulmonary function among four categories of metabolic syndrome and 
diabetes status (Table 6). Because a high percentage of adults with diabetes have metabolic 
syndrome, the number of diabetic participants without metabolic syndrome was relatively 
small. Participants with both conditions had the lowest mean levels of FEV1, FEV1 % 
predicted, FVC, and FVC % predicted, but the highest FEV1/FVC ratio. Although that 
pattern persisted among adults with a BMI between 25 and <30 kg/m2, only differences for 
FVC % predicted remained significant (Table S3). Comparisons among the four groups for 
adults with a BMI between 18.5 and <25 kg/m2 and those with a BMI ≥30 kg/m2 were not 
feasible because of small sample sizes in some groups.
The prevalence of metabolic syndrome and all five components was highest among 
participants with a restrictive impairment (Table 7). The prevalence of metabolic syndrome, 
abdominal obesity, and lipid abnormalities was lowest among participants with obstructive 
impairment, and the prevalence of elevated blood pressure and hyperglycemia was lowest 
among participants with a normal pulmonary function test. Upon multivariate analysis, 
restrictive impairment was associated with prevalence of metabolic syndrome and all five 
components (Table 7). However, mild obstructive impairment was associated with a reduced 
prevalence of metabolic syndrome, abdominal obesity, and hypertriglyceridemia. Any 
obstructive impairment was also associated with a reduced prevalence of metabolic 
syndrome (adjusted prevalence ratio [aPR] 0.77; 95% confidence interval [CI] 0.67, 0.88), 
abdominal obesity (aPR 0.85; 95% CI 0.77, 0.93), and hypertriglyceridemia (aPR 0.67; 95% 
CI 0.55, 0.83).
Discussion
Our analyses indicate that US adults with metabolic syndrome tend to be characterized by a 
restrictive pattern on spirometry and have a lower prevalence of an obstructive pattern. 
Furthermore, mean levels of FEV1, FEV1 % predicted, FVC, and FVC % predicted were 
lower among participants with metabolic syndrome compared with those without metabolic 
syndrome, but the reverse was evident for the FEV1/FVC ratio. Furthermore, participants 
with both metabolic syndrome and diabetes had the lowest mean levels of FEV1, FEV1 % 
predicted, FVC, and FVC % predicted and the highest FEV1/FVC ratio. Conversely, the 
prevalence of metabolic syndrome was higher among participants with a restrictive lung 
function pattern and lower among participants with obstructive impairment than participants 
with normal lung function.
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Previous studies have produced mixed findings regarding pulmonary function in adults with 
and without metabolic syndrome. In a case control study (38 patients with COPD, 34 control 
patients), 47% of patients with COPD and 21% of controls had metabolic syndrome.13 In a 
Taiwanese study that included 46 514 participants aged ≥20 years from 1998 to 2000, 
restrictive lung function (odds ratio [OR] 1.221 [95% CI 1.086, 1.3272]; and OR 1.150 
[95% CI: 1.047–1.264]), but not obstructive lung function or mixed lung function, was 
significantly associated with metabolic syndrome.3 The analyses were adjusted for age, 
gender, BMI, alcohol use, smoking, and physical activity. In a cross-sectional study of 159 
non-diabetic elderly adults during 2002–03, a restrictive pattern (OR 3.23; 95% CI 1.23, 
8.48), but not an obstructive one, was associated with prevalent metabolic syndrome after 
adjustment for age, gender, waist circumference, and BMI.14 A study from Japan that 
included 2396 apparently healthy adults aged 30–80 years found that a restrictive pattern, 
but not an obstructive one, was associated with metabolic syndrome.2 Three definitions of 
metabolic syndrome were used in that study, and ORs ranged from 1.95 to 2.56 after 
adjustment for age, gender, height, and smoking status. An analysis of the Korean National 
Health and Nutrition Survey from 2001 included 4001 participants aged ≥18 years.4 A 
restrictive pattern, but not an obstructive one was associated with metabolic syndrome (OR 
1.40; 95% CI 1.01, 1.98). The results were adjusted for age, gender, pack-years of smoking, 
physical activity, alcohol intake, socioeconomic status, and waist/height ratio. However, a 
subsequent analysis of the 2001 Korean National Health and Nutrition Examination Survey 
that included 1215 participants aged ≥40 years reported that ORs for the presence of COPD 
were elevated among those with metabolic syndrome (OR 1.78 [95% CI 1.00, 3.16] in men; 
OR 1.39 [95% CI 0.66, 2.95] in women).5 Age, alcohol intake, education, household 
income, and smoking status were included as adjustment factors. Another Korean study 
included 1951 non-smoking men aged ≥30 years in 2008 and found that the prevalence of 
metabolic syndrome decreased as FVC increased.6 A fourth Korean study of 9581 healthy 
non-smoking men (mean age 40.9 years) who underwent a health examination in 2005 
reported that the metabolic syndrome was a significant predictor of a restrictive pattern (OR 
1.55; 95% CI 1.12, 2.14). but not an obstructive one (OR 1.39; 95% CI 0.66, 2.94).7 The 
results were adjusted for age, BMI, physical activity, and CRP. A Chinese study that 
included 7358 adults aged ≥50 years from 2003 to 2006 observed that participants with 
COPD (OR 1.47; 95% CI 1.12–1.92) and notably participants with severe airflow 
obstruction (OR 2.34; 95% CI 1.39–3.95) had significantly increased odds of having 
metabolic syndrome.8 The results were adjusted for age, gender, education, smoking, 
physical activity, and BMI. Restrictive lung disease was not examined in that study. Thus, 
the preponderance of studies have found that metabolic syndrome is associated with a 
restrictive pattern and not with an obstructive one. Our findings agree with this assessment.
A couple of other studies reported on spirometric parameters as a function of the metabolic 
syndrome status. Among 2396 participants of the Strong Heart Study, mean levels of FEV 
% predicted and FVC % predicted were lower in participants with metabolic syndrome than 
in those without it.15 Adjustments were made for age, gender, education, smoking status, 
abdominal obesity, height, hypertension, physical activity, and center. In a Korean study that 
included 1370 patients aged 20–70 years who had a health examination in 2008, men who 
had metabolic syndrome had higher mean levels of FEV1 and FVC than men without 
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metabolic syndrome, and women with metabolic syndrome had higher levels of FEV1 and 
FEV1/FVC than women without metabolic syndrome.16 Furthermore, FEV1 and FVC both 
declined as a function of the number of metabolic syndrome components in men, but the 
pattern in women was irregular. Physical activity and smoking status were controlled for in 
the analyses. Our results generally agree with the findings of these studies.
Several studies have examined prevalent metabolic syndrome as a function of pulmonary 
parameters such as FEV1, FVC, and FEV1/FVC. A Korean study that included 4905 men 
aged >40 years who received an annual medical check-up during 2005–08 showed that the 
OR for having metabolic syndrome increased as a function of declining quartiles of FVC % 
predicted and FEV1 % predicted after adjustment for age, smoking status, and BMI.17 In a 
study of 237 firefighters in New York City who were being monitored as a result of 
exposures received during 11 September 2001, the prevalence of metabolic syndrome was 
higher among firefighters with FEV1 % predicted less than the lower limit of normal (27%) 
than among those with an FEV1 % predicted greater than the lower limit of normal (16%; P 
= 0.07).18 In a Japanese study of 273 working men (mean age 44 years), the prevalence of 
metabolic syndrome increased as a function of decreasing FEV1 and FVC after adjustment 
for age, smoking status, and BMI.19
Our results indicate that patients presenting with metabolic syndrome are unlikely to have 
obstructive lung disease in excess of what physicians may expect to encounter in their 
patient populations in general. Instead, these patients are somewhat more likely to present 
with restrictive lung disease. Restrictive lung disease can result from a variety of causes, 
such as idiopathic fibrosis, sarcoidosis, chest wall deformities, scoliosis, neuromuscular 
disorders, and obesity. Because abdominal obesity is the major component of metabolic 
syndrome among US adults, excess weight is the most likely cause for restrictive lung 
function among patients with metabolic syndrome, and weight loss should improve 
pulmonary function in many patients with metabolic syndrome and alleviate symptoms 
caused by restrictive lung functioning.
In our analyses, participants with obstructive pulmonary functioning did not have an excess 
of metabolic syndrome. Because approximately 25% of adults who have obstructive lung 
disease also have metabolic syndrome, metabolic syndrome is a common comorbidity in 
these patients despite the fact that it does not occur more frequently in obstructive 
impairment than in adults without obstructive impairment. Nevertheless, patients with 
metabolic syndrome are likely to be treated for high blood pressure, dyslipidemias, and 
hyperglycemia. Thus, the potential for polypharmacy in patients with both COPD and 
metabolic syndrome is a challenge that physicians need to take into account when treating 
patients with COPD.
Suboptimal sample size was a limitation for analyses exploring the associations between 
severe obstructive impairment and metabolic syndrome and its components, as well as 
analyses that stratified by covariates. Because we only used prebronchodilator data, our 
analyses included some percentage of participants with a reversible airways limitation. 
Although post-bronchodilator spirometry was conducted, asizable percentage of participants 
did not participate in this part of the protocol and, therefore, we did not use these data.
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In conclusion, participants with metabolic syndrome were more likely to have a restrictive 
pattern on spirometry than those without metabolic syndrome. Obstructive impairment did 
not differ significantly between participants with and without metabolic syndrome. Because 
restrictive impairment is likely to be caused by abdominal obesity in many of the adults with 
metabolic syndrome, weight loss should prove helpful in improving pulmonary function and 
alleviating respiratory symptoms.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Significant findings of the study
Compared with adults who did not have metabolic syndrome (MetS), adults who did 
have MetS were significantly more likely to have a restrictive pattern of lung function, 
but not an obstructive pattern. Participants with both MetS and diabetes had the lowest 
mean levels of forced expiratory volume in one second (FEV1), FEV1% predicted, forced 
vital capacity (FVC), and FVC % predicted and the highest FEV1/FVC ratio.
What this study adds
Lung function in adults with MetS remains poorly characterized, and this study provides 
new insights into the associations between MetS and lung function in a representative 
sample of adults in the US.
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Table 3
Adjusted prevalence ratios (95% confidence intervals) for associations between restrictive and obstructive 
impairment (dependent variable) and metabolic syndrome and its components (independent variables) among 
US adults aged ≥20 years, National Health and Nutrition Examination Survey 2007–2010
Predictor Restrictive impairment Any obstructive impairment
Age-adjusted models
 Metabolic syndrome (%) 2.36 (1.78, 3.12) 0.75 (0.63, 0.88)
 Abdominal obesity (%) 1.34 (0.95, 1.88) 0.65 (0.54, 0.78)
 Hypertriglyceridemia (%) 1.79 (1.27, 2.54) 0.76 (0.62, 0.94)
 Low HDL-C (%) 2.35 (1.81, 3.05) 0.91 (0.66, 1.26)
 Elevated blood pressure (%) 1.87 (1.38, 2.54) 1.04 (0.85, 1.27)
 Hyperglycemia (%) 1.79 (1.26, 2.54) 1.13 (0.89, 1.44)
Multiple-adjusted models*
 Metabolic syndrome (%) 2.20 (1.67, 2.90) 0.73 (0.62, 0.86)
 Abdominal obesity (%) 1.66 (1.24, 2.23) 0.75 (0.64, 0.89)
 Hypertriglyceridemia (%) 1.52 (1.10, 2.12) 0.69 (0.56, 0.84)
 Low HDL-C (%) 2.02 (1.57, 2.59) 0.86 (0.62, 1.20)
 Elevated blood pressure (%) 1.84 (1.35, 2.50) 1.02 (0.86, 1.22)
 Hyperglycemia (%) 1.52 (1.07, 2.17) 0.98 (0.77, 1.25)
*
Adjusted for age, gender, race or ethnicity, educational status, smoking status, physical activity, alcohol use, and concentration of C-reactive 
protein.
HDL-C, high-density lipoprotein–cholesterol.
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